Roth Capital Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $5.5

Benzinga · 3d ago
Roth Capital analyst Kyle Bauser initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Buy rating and announces Price Target of $5.5.